research use only
Cat.No.S4206
|
In vitro |
DMSO
: 23 mg/mL
(202.44 mM)
Water : 23 mg/mL Ethanol : 23 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 113.61 | Formula | C2H7NS.HCl |
Storage (From the date of receipt) | 3 years -20°C powder (seal) |
|---|---|---|---|---|---|
| CAS No. | 156-57-0 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | Mercaptamine | Smiles | C(CS)N.Cl | ||
| In vitro |
Cysteamine HCl has been shown to increase intracellular glutathione levels in cystinotic cells, thus restoring the altered redox state of the cells. Also increased rates of apoptosis in cystinotic cells, which are thought to be the result of increased caspase 3 and protein kinase Cε activity, is counteracted by this compound administration. It has antioxidant properties as a result of increasing glutathione production. This chemical is an excellent scavenger of OH and HOCl; it also reacts with H2O2. This agent increases the production of several heat shock proteins (HSP), including the murine Hsp40. It exerts a dose-dependent effect on the doxorubicin-induced death of cancer cells, measured in both HeLa cells and B16 cells, whereas this compound treatment alone had no influence on cell survival. In addition, in a doxorubicin-resistant breast cancer cell line, the addition of this chemical to doxorubicin results in a dramatic increase in cell death. This compound (100 μM) significantly is able to increase the intracellular GSH levels and the percentage of embryos that developed to the blastocyst stage of culture matured oocytes. |
|---|---|
| In vivo |
Cysteamine is introduced as a treatment for cystinosis by depleting lysosomal cystine. This compound can inhibit transglutaminase activity by binding to the cysteine in its active center. It increases brain levels of brain-derived neurotrophic factor (BDNF), which is caused by the increased expression of the heat shock DNAJ-containing protein 1 (HSJ1). This chemical inhibits the formation of gastric and mammary tumors that are induced chemically or after irradiation, respectively. The administration of this compound is also able to inhibit the metastasis of pancreatic cancer in a mouse model by decreasing the expression and activity of metalloproteinases. |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.